Red-light-activated PL-5 nanoliposomes quadruple antimicrobial potency against MRSA and MSSA biofilms in vitro.
Background
Burn wound infections are frequently complicated by biofilm-forming and multidrug-resistant pathogens, particularly methicillin-resistant Staphylococcus aureus (MRSA), posing major therapeutic challenges. Current standard-of-care often struggles against these persistent infections. Antimicrobial peptides (AMPs) like PL-5 (peceleganan) offer broad-spectrum activity but are limited by instability, poor biofilm penetration, and reduced efficacy in complex wound environments. This research addresses the need for enhanced delivery and activation strategies to overcome these limitations.
Study Design
Researchers developed a red-light-responsive, porphyrin-phospholipid (PoP)-containing cationic liposomal system for PL-5 (peceleganan). Optimized liposomes achieved a high encapsulation efficiency of approximately 73%, a uniform nanoscale size of around 50 nm, narrow polydispersity, and a positive surface charge. They evaluated storage stability and controlled peptide release under red-light irradiation (635 nm). In vitro antimicrobial activity was assessed against MRSA and methicillin-susceptible S. aureus (MSSA), comparing light-activated liposomes to free PL-5 and non-irradiated liposomes. Primary endpoints included minimum inhibitory concentration (MIC) values, bactericidal kinetics, and biofilm formation inhibition.
Results
The optimized liposomal system for PL-5 demonstrated good storage stability and controlled peptide release upon red-light irradiation. In vitro, red-light activation significantly enhanced antimicrobial activity against both MRSA and MSSA. This activation led to a substantial reduction in MIC values, which were decreased fourfold compared with free PL-5 and non-irradiated liposomes.
Red-light activation significantly enhanced antimicrobial activity against MRSA and MSSA, reducing minimum inhibitory concentration (MIC) values fourfold and accelerating bactericidal kinetics compared with free PL-5 and non-irradiated liposomes. Furthermore, the light-activated liposomes markedly inhibited biofilm formation, a critical factor in persistent infections. The liposomes themselves achieved a high encapsulation efficiency of approximately 73% and maintained a uniform nanoscale size of about 50 nm.
Key Findings
- PL-5 nanoliposomes achieved high encapsulation efficiency (~73%) and uniform nanoscale size (~50 nm).
- Red-light activation reduced PL-5 minimum inhibitory concentration (MIC) values against MRSA/MSSA fourfold.
- Light-activated PL-5 accelerated bactericidal kinetics against both MRSA and MSSA.
- Red-light-activated PL-5 liposomes markedly inhibited biofilm formation in vitro.
Why It Matters
This study demonstrates a promising strategy for localized, spatiotemporally controlled treatment of biofilm-associated burn wound infections. By enhancing the stability, penetration, and efficacy of PL-5 through light-activated nanoliposomes, this approach could significantly improve outcomes for challenging MRSA and MSSA infections. For biohackers and clinicians, this highlights the potential of combining antimicrobial peptides with advanced delivery systems and photodynamic therapy to overcome antibiotic resistance. While currently an in vitro finding, it lays a strong foundation for future translational studies, potentially leading to a novel clinical protocol that could reduce systemic antibiotic use and improve wound healing.
pl-5
peceleganan
mrsa
mssa
biofilm
antimicrobial